
The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

